The drugs industry closed the day up 1.9%. Cormedix Inc ( CRMD), Uluru Inc ( ULU), CEL-SCI Corporation ( CVM), and Palatin Technologies Inc ( PTN) were all decliners today within the drugs industry with Vertex Pharmaceuticals ( VRTX) being today's featured drugs loser. Vertex Pharmaceuticals fell $2.64 (-6.5%) to $43.13 on heavy volume. Throughout the day, 3.4 million shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 2.1 million shares. Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Vertex Pharmaceuticals has a market cap of $9.3 billion and is part of the health care sector. Shares are up 15.6% year to date as of the close of trading on Monday. TheStreet Ratings rates Vertex as a sell. The company's weaknesses can be seen in multiple areas, such as its generally weak debt management and disappointing return on equity.
- You can view the full Vertex Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.